SCHEMBL18927140

SCHEMBL18927140

CC1=NC(c2cc(Br)ccc2C)(C2CCC(OC(F)F)CC2)N=C1N

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.58
APP P05067 14/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18561593 0.86 BACE1 (0.55) BACE1APP
SCHEMBL18926585 0.84 BACE1 (0.59) BACE1APP
SCHEMBL18927252 0.83 BACE1 (0.61) BACE1APP
SCHEMBL18927263 0.83 BACE1 (0.44) BACE1APP
SCHEMBL18927235 0.81 BACE1 (0.41) BACE1APP
SCHEMBL21654395 0.78 BACE1 (0.65) BACE1APP
SCHEMBL18926581 0.77 BACE1 (0.65) BACE1APP
SCHEMBL18926240 0.77 BACE1 (0.66) BACE1APP
SCHEMBL18926471 0.76 BACE1 (0.66) BACE1APP
SCHEMBL18927162 0.76 BACE1 (0.52) BACE1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3176172-B1 SPIROIMIDAZOLE COMPOUNDS AND THEIR USE AS BACE INHIBITORS ASTRAZENECA AB (SE) 2020-01-29 EP disclosed
EP-3176172-A1 SPIROIMIDAZOLE COMPOUNDS AND THEIR USE AS BACE INHIBITORS Astrazeneca AB (SE) 2017-06-07 EP disclosed